PL1681059T3 - Kompozycja farmaceutyczna zawierająca prostaglandynę - Google Patents

Kompozycja farmaceutyczna zawierająca prostaglandynę

Info

Publication number
PL1681059T3
PL1681059T3 PL04818172T PL04818172T PL1681059T3 PL 1681059 T3 PL1681059 T3 PL 1681059T3 PL 04818172 T PL04818172 T PL 04818172T PL 04818172 T PL04818172 T PL 04818172T PL 1681059 T3 PL1681059 T3 PL 1681059T3
Authority
PL
Poland
Prior art keywords
prostaglandin
pharmaceutical composition
composition containing
water
containing prostaglandin
Prior art date
Application number
PL04818172T
Other languages
English (en)
Inventor
Yusuke Sakai
Akira Ohtori
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of PL1681059T3 publication Critical patent/PL1681059T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL04818172T 2003-11-07 2004-10-26 Kompozycja farmaceutyczna zawierająca prostaglandynę PL1681059T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003378196 2003-11-07
PCT/JP2004/015828 WO2005044276A1 (ja) 2003-11-07 2004-10-26 プロスタグランジン含有医薬組成物
EP04818172A EP1681059B1 (en) 2003-11-07 2004-10-26 Pharmaceutical composition containing prostaglandin

Publications (1)

Publication Number Publication Date
PL1681059T3 true PL1681059T3 (pl) 2010-01-29

Family

ID=34567167

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04818172T PL1681059T3 (pl) 2003-11-07 2004-10-26 Kompozycja farmaceutyczna zawierająca prostaglandynę

Country Status (10)

Country Link
US (2) US20080139652A1 (pl)
EP (1) EP1681059B1 (pl)
JP (1) JP4762718B2 (pl)
KR (1) KR101091461B1 (pl)
CN (1) CN100484528C (pl)
AT (1) ATE442146T1 (pl)
DE (1) DE602004023106D1 (pl)
ES (1) ES2331313T3 (pl)
PL (1) PL1681059T3 (pl)
WO (1) WO2005044276A1 (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005304034B2 (en) 2004-11-09 2012-02-16 Santen Sas Ophthalmic emulsions containing an immunosuppressive agent
PT1873448E (pt) 2005-03-31 2010-11-11 Neobulb Technologies Inc Um equipamento de iluminação com led de alta potência, dispondo de uma elevada difusibilidade térmica
US8030349B2 (en) * 2005-08-02 2011-10-04 Santen Pharmaceutical Co., Ltd. Method for prevention of degradation of thermally unstable medicament
BRPI0616041A2 (pt) * 2005-09-16 2011-06-07 Allergan Inc composições e métodos para o transporte intra-ocular de agentes terapêuticos
EP1937212B1 (en) * 2005-10-10 2010-09-01 Novagali Pharma S.A. Ophthalmic emulsions containing prostaglandins
CN103768070A (zh) * 2006-03-13 2014-05-07 株式会社·R-技术上野 水性组合物
DE102006049091A1 (de) * 2006-10-18 2008-04-24 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl
US20100120908A1 (en) 2007-02-07 2010-05-13 Teika Pharmaceutical Co., Ltd Eye drop preparation comprising latanoprost
EP1985298A1 (en) * 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
EP2172202A4 (en) 2007-06-29 2010-06-30 Taisho Pharmaceutical Co Ltd AQUEOUS LIQUID AGENT CONTAINING A PROSTAGLANDINE DERIVATIVE
JP2009073788A (ja) * 2007-09-21 2009-04-09 Teika Seiyaku Kk イソプロピルウノプロストン含有眼用組成物
TW201010708A (en) * 2008-06-02 2010-03-16 Intervet Int Bv Composition comprising an antibiotic and a corticosteroid
FR2938757B1 (fr) * 2008-11-27 2010-12-31 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation cosmetique ou dermatologique
EP2228058A1 (en) * 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
MX361709B (es) 2009-11-09 2018-12-07 Allergan Inc Composiciones y metodos para estimular el crecimiento del cabello.
US20110112198A1 (en) * 2009-11-09 2011-05-12 Allergan, Inc. Compositions for enhancing hair growth
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
IT1404931B1 (it) * 2010-06-11 2013-12-09 Medivis S R L Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
EP2714007A2 (en) * 2011-05-27 2014-04-09 Ratiopharm GmbH Ophthalmic preparation comprising a pgf2alpha analogue
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
JP6511401B2 (ja) 2013-02-15 2019-05-15 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 持続型薬物送達インプラント
JP7044714B2 (ja) 2016-11-17 2022-03-30 千寿製薬株式会社 乳剤点眼液
WO2019026992A1 (ja) * 2017-08-03 2019-02-07 参天製薬株式会社 クロルヘキシジンを含有する医薬組成物
KR102365008B1 (ko) * 2020-06-23 2022-02-23 주식회사태준제약 디쿠아포솔을 포함하는 점안 조성물
CN115463088A (zh) * 2021-06-11 2022-12-13 温士顿医药股份有限公司 含前列腺素衍生物的眼用纳米乳剂组合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
JPS6051105A (ja) * 1983-08-30 1985-03-22 Green Cross Corp:The プロスタグランジン脂肪乳剤
CA1324129C (en) 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US4839371A (en) * 1987-09-17 1989-06-13 Smithkline Beckman Corporation 3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
DE68929435T2 (de) 1988-09-06 2003-07-17 Pharmacia Ab Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
JPH0710833A (ja) 1991-04-16 1995-01-13 Yutaka Mizushima プロスタグランジン類縁体、その脂肪乳剤およびその用途
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5767153A (en) * 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
US5767135A (en) * 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
JP4421699B2 (ja) 1999-06-30 2010-02-24 大洋薬品工業株式会社 静脈注射可能なプロスタグランジン脂肪乳剤
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
JP3876355B2 (ja) 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
KR100854056B1 (ko) * 2000-09-13 2008-08-26 산텐 세이야꾸 가부시키가이샤 점안액
US6635654B1 (en) * 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine

Also Published As

Publication number Publication date
DE602004023106D1 (de) 2009-10-22
EP1681059B1 (en) 2009-09-09
WO2005044276A1 (ja) 2005-05-19
EP1681059A1 (en) 2006-07-19
US8697751B2 (en) 2014-04-15
KR20060123215A (ko) 2006-12-01
KR101091461B1 (ko) 2011-12-07
CN100484528C (zh) 2009-05-06
JP4762718B2 (ja) 2011-08-31
JPWO2005044276A1 (ja) 2007-05-17
US20080139652A1 (en) 2008-06-12
ES2331313T3 (es) 2009-12-29
EP1681059A4 (en) 2007-10-10
ATE442146T1 (de) 2009-09-15
CN1871014A (zh) 2006-11-29
US20110294880A1 (en) 2011-12-01

Similar Documents

Publication Publication Date Title
PL1681059T3 (pl) Kompozycja farmaceutyczna zawierająca prostaglandynę
EA200801602A1 (ru) Эмульсия
KR890011586A (ko) 지용성물질의 수용액
HK1067277A1 (en) Microbiocidal formulation comprising essential oils or their derivatives
EA201170433A1 (ru) Полисахаридная капсула, включающая в себя эмульсию, содержащую масло жирных кислот
WO2006052662A3 (en) High pufa oil compositions
BRPI0416877A (pt) método para reduzir odor de fezes de um animal doméstico
AR032200A1 (es) Productos antitranspirantes
EA201201380A1 (ru) Термически стабильные эмульсии "масло-в-воде", содержащие масло, которое содержит полиненасыщенные жирные кислоты
CA2495230A1 (en) Protection of fragrance in a wax candle using an antioxidant
BR112020019776A2 (pt) Uso inovador de croman-6-óis substituídos
CL2008001180A1 (es) Un polvo bebestible instantaneo que comprende un agente de relleno y/o azucar recubiertas al menos parcialmente con un 0,1-5% de aceite de cadenas cortas de acidos grasos saturados de trigleceridos saturados c4-c14; capsula que comprende el polvo bebestible; metodo de produccion del polvo; kit que comprende un polvo bebestible.
CL2011000462A1 (es) Composicion de aceite que contiene aceite y caldo, en que la proporcion de aceite a caldo varia desde 1:1 hasta 1:3; metodo de preparacion de dicha composicion; uso de dicha composicion; y metodo para la preparacion de productos a base de carne que contienen aceite.
BRPI0705244A (pt) composição oleosa de ácido linolênico conjugado
DE602005019207D1 (de) Orale zusammensetzung zur verbesserung der hauteigenschaften
BRPI0413845A (pt) antioxidante que é baseado em ácido ascórbico, uso do antioxidante, e, preparação de gordura alimentìcia ou óleo alimentìcio
ES2561207T3 (es) Emulsión grasa para alimentar artificialmente a pacientes gravemente enfermos de cuidados intensivos
BRPI0907298B8 (pt) preparação solúvel em água, sólida e no formato de película compreendendo álcool de polivinila e substância oleosa, e método para produzí-la
WO2009020128A1 (ja) クロレラ抽出物含有物及びその保存安定性向上法
CH700328B8 (de) O/W-Emulsion zur Pflege der Hand.
BRPI0515708A (pt) emulsão acidificada comestìvel em óleo-e-água e processo para o preparo de uma emulsão
BRPI0408849A (pt) agente de modificação de carne, método de produção de produto de carne e produto de carne
WO2008143090A1 (ja) 油中水型乳化組成物
ATE549943T1 (de) Verfahren zur herstellung von sojasaucenpulver
IL190752A0 (en) Packaged oxidation-stable oil-in water emulsion